Auna (AUNA) Fundamentals 2026 — Revenue Analysis | SniperIQ
Auna (AUNA) is a LU-listed Healthcare company in Medical - Care Facilities with a market capitalization of
Auna (AUNA) has a market capitalization of approximately
Auna's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
Auna runs a net profit margin of 1.5%, a gross margin of 37.9%, and an operating margin of 14.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Auna reported revenue of PEN 4.4B for fiscal year 2025, with net income of PEN 98M and earnings per share (EPS) of 3.06. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Auna does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Auna carries a debt-to-equity ratio of 2.19x and a current ratio of 1.09x, with a market beta of 0.61. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Auna (AUNA) the key facts are: market cap
Get Auna's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.